Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy

MeSH terms

• Antineoplastic Agents / administration & dosage*
• Benzamides
• Dasatinib
• Drug Resistance, Neoplasm / drug effects*
• Drug Resistance, Neoplasm / genetics
• Female
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
• Middle Aged
• Philadelphia Chromosome
• Piperazines*
• Protein Kinase Inhibitors
• Pyrimidines / administration & dosage*
• Remission Induction
• Thiazoles*
• Time Factors